SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Villarreal-Garza C.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:48
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Prospective patient navigation program for young women with breast cancer: assessment and referrals to address medical and supportive care needs (2026)
 
2.- Impact of germline genetic variation on breast cancer prognosis: a systematic review and meta-analysis (2026)
 
3.- Corrigendum to ?Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer? (2026)
 
4.- Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial (2025)
 
5.- Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort (2025)
 
6.- Psychosocial understanding of unmet needs in newly diagnosed breast cancer patients (2025)
 
7.- Correction: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior (Cancers, (2021), 13, 24, (6256), 10.3390/cancers13246256) (2025)
 
8.- Mexican Breast Cancer Women and Their Partners: Individual and Couple Analysis (2024)
 
9.- Evaluation of a Proteomics-Guided Protein Signature for Breast Cancer Detection in Breast Tissue (2024)
 
10.- Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women (2024)
 
11.- Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer (2022)
 
12.- Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case?control study (2021)
 
13.- Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America (2021)
 
14.- Breast cancer associated pathogenic variants among women 61?years and older with triple negative breast cancer (2021)
 
15.- Prospective Study of Fertility Preservation in Young Women With Breast Cancer in Mexico (2021)
 
16.- Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication (2021)
 
17.- Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (2020)
 
18.- Young women with breast cancer in Mexico: Results of the pilot phase of the Joven & Fuerte prospective cohort (2020)
 
19.- Patients? satisfaction with a supportive care program for young breast cancer patients in Mexico: Joven & Fuerte supports patients? needs and eases their illness process (2020)
 
20.- Gaps in Knowledge and Understanding of Patients With Metastatic Breast Cancer in Mexico (2020)
 
21.- Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms (2020)
 
22.- Breast cancer treatment: A phased approach to implementation (2020)
 
23.- Necesidades insatisfechas de cuidadores primarios de pacientes con cáncer de mama: Percepción diádica (2020)
 
24.- Locally advanced breast cancer in young women in Latin America (2019)
 
25.- Medical and information needs among young women with breast cancer in Mexico (2019)
 
26.- Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients (2019)
 
27.- Validación del Cuestionario de Regulación Emocional Cognitiva en pacientes mexicanas con cáncer de mama (2018)
 
28.- Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer (vol 10, 88, 2018) (2018)
 
29.- Suboptimal use of effective contraceptive methods in young Mexican women with breast cancer (2018)
 
30.- Mujeres jóvenes con cáncer de mama: Necesidades de apoyo en atención y resiliencia (2018)
 
31.- Clinical characteristics and outcomes of older women with breast cancer in Mexico (2018)
 
32.- Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer (2018)
 
33.- Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy (2018)
 
34.- Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer (2017)
 
35.- Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular (2017)
 
36.- The impact of the use of intraoperative radiotherapy on costs, travel time and distance for women with breast cancer in the Mexico City Metropolitan Area (2017)
 
37.- Special needs of young women with breast cancer in limited resource settings (2017)
 
38.- A study of the impact of the 21-gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a mexican public hospital (2015)
 
39.- The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer (2015)
 
40.- Cost-Effectiveness of the 21-Gene Breast Cancer Assay in Mexico (2015)
 
41.- HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the ß-chain are protective in Mexican Mestizos (2004)
 
42.- Angiotensin-Converting Enzyme Gene (ACE) Insertion/Deletion Polymorphism in Mexican Populations (2003)
 
43.- Distribution of HLA-B alleles in Mexican Amerindian populations (2003)
 
44.- Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis (2003)
 
45.- HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis (2003)
 
46.- HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever (2002)
 
47.- Communication Challenges Among Oncologists in Mexico ()
 
48.- Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.